21
Mar

Celgene picked up the FDA’s blessing for the much-debated apremilast, winning approval to market the oral drug as a treatment for psoriatic arthritis in step one of its blockbuster plan.

…read more

Source: Celgene wins FDA approval for its blockbuster arthritis contender

    

0 No comments